Annie van Broekhoven

Vorstandsvorsitzender bei Q-Biologicals NV

Health Technology

Profil

Annie van Broekhoven currently holds executive and director positions in Q-Biologicals NV and is currently the Chief Executive Officer and Director.
She is also an Independent Director in Biogazelle NV.

Aktive Positionen von Annie van Broekhoven

Unternehmen	Position	Beginn
Q-Biologicals NV Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium.	Vorstandsvorsitzender	24.10.2011
Biogazelle NV Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Annie van Broekhoven

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Annie van Broekhoven im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Q-Biologicals NV Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium.	Health Technology
Biogazelle NV Biogazelle NV BiotechnologyHealth Technology Biogazelle NV is a research and development stage biotechnology firm. It specializes in ribonucleic acid for next generation diagnostics in the field of oncology and other diseases. The company was founded by Jan Hellemans and Jo Vandesompele in 2007 and is headquartered in Zwijnaarde, Belgium.	Health Technology

Sehen Sie sich die Unternehmensverbindungen an